| Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients | |
| Jiang, Nian-Xin; Ge, Jun-Wei; Xian, Yu-Qiong; Huang, Shao-Ying; Li, Yan-Song | |
| 刊名 | BIOMEDICAL REPORTS
 |
| 2016 | |
| 卷号 | 4期号:4 |
| 关键词 | atrial fibrillation warfarin cytochrome P450 2C9 single nucleotide polymorphisms vitamin K epoxide reductase complex 1 |
| ISSN号 | 2049-9434 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3646736 |
| 专题 | 上海中医药大学 |
| 推荐引用方式 GB/T 7714 | Jiang, Nian-Xin,Ge, Jun-Wei,Xian, Yu-Qiong,et al. Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients[J]. BIOMEDICAL REPORTS,2016,4(4). |
| APA | Jiang, Nian-Xin,Ge, Jun-Wei,Xian, Yu-Qiong,Huang, Shao-Ying,&Li, Yan-Song.(2016).Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients.BIOMEDICAL REPORTS,4(4). |
| MLA | Jiang, Nian-Xin,et al."Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients".BIOMEDICAL REPORTS 4.4(2016). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论